TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/9/23 16:15 | 6/9/23 | FNCH | Finch Therapeutics Group, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Graf Susan E | MA | D | P.d | 1 | 0.2700 | 0 | 5 | New | 5 | D | |||||||||||||||
2/20/15 16:47 | 2/12/15 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Graf Susan E | NJ | O | VP,Corp | M.d | 0 | 0.00 | 0 | 1 | 44 | 5 | D | ||||||||||||||
2/11/15 12:32 | 2/10/15 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Graf Susan E | NJ | O | VP,Corp | M.d | 100 | 14.90 | 0 | 7 | 4 | D | |||||||||||||||
2/11/15 12:32 | 2/10/15 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Graf Susan E | NJ | O | VP,Corp | S.d | -308 | 45.87 | 0 | -7 | -64 | 4 | D | ||||||||||||||
6/19/14 15:39 | 6/17/14 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Graf Susan E | NJ | O | VP,Corp | M.d | 0 | 0.00 | 0 | 6 | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |